# Federalist Radio Hour: Reclaiming Medicine And Biotech From China

Page: https://stenobird.com/podcast/the-ricochet-superfeed-446950/federalist-radio-hour-reclaiming-medicine-and-biotech-from-china
Text version: https://stenobird.com/podcast/the-ricochet-superfeed-446950/federalist-radio-hour-reclaiming-medicine-and-biotech-from-china.md
Podcast: [The Ricochet Superfeed](https://stenobird.com/podcast/the-ricochet-superfeed-446950)
Published: 2026-07-10T17:14:51+00:00
Episode link: https://ricochet.com/podcast/federalist-radio-hour/reclaiming-medicine-and-biotech-from-china/
Audio file: https://dts.podtrac.com/redirect.mp3/pdst.fm/e/mgln.ai/e/35/api.spreaker.com/download/episode/72873217/frh07_10_2026.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-ricochet-superfeed-446950/episodes/federalist-radio-hour-reclaiming-medicine-and-biotech-from-china
Duration seconds: 2473

## Resource

On this edition of The Federalist Radio Hour, Executive Chairman of Ovid Therapeutics Dr. Jeremy Levin joins Federalist Senior Elections Correspondent Matt Kittle to discuss how the biotech industry is essential for American healthcare and security, and how China has strategically advanced its biotech industry to overtake the United States’. They also discuss the distrust Americans […]

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-ricochet-superfeed-446950/episodes/federalist-radio-hour-reclaiming-medicine-and-biotech-from-china/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-ricochet-superfeed-446950/federalist-radio-hour-reclaiming-medicine-and-biotech-from-china.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.